This month, our discussion continues about the newly released American College of Medical Genetics and Genomics (ACMG) clinical practice resource for adults with NF1. The resource, written for general ...

In the opinion of R. Rox Anderson, MD, patients with neurofibromatosis type 1 (NF1) have long been underserved in the medical field. Affected children are born with café-au-lait spots and sometimes ...

Please provide your email address to receive an email when new articles are posted on . Small cNFs were successfully reduced with four different nonsurgical treatment modalities. Deoxycholate and ...

Researchers from the Germans Trias i Pujol Research Institute (IGTP) have made progress in exploring potential treatments for skin tumours associated with neurofibromatosis type 1. Their findings in ...

This month, our discussion focuses on the clinical management of plexiform neurofibromas in the era of selumetinib, a MEK inhibitor medication that was approved by the FDA in 2020 for the treatment of ...

WAYNE, Pa.--(BUSINESS WIRE)--NFlection Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel drug candidates for rare RASopathies, today announced that the Food ...

While the first medical treatment for neurofibromatosis (NF) was recently approved, many further options are on the horizon. "You see a massive acceleration of research and development," said Annette ...

Please provide your email address to receive an email when new articles are posted on . Quality of life impairment was most associated with facial involvement and the number of neurofibromas.

Q: A doctor said the rashes on my son's back were “coffee spots” and that meant he might have neurofibromatosis. I read there is a new treatment for this condition; is it a cure? A: Café-au-lait spots ...